source
- STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drugCEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.STAT · 2mo ago↗ source
- Can AI do scientific research?; The 'magic bullet' search has faded in immunotherapy; and moreWelcome back to Endpoints Weekly! We’ve got a team of reporters on the ground in Chicago this weekend for ASCO, including my fellow Weekly co-author Max Gelman. If you haven’t already, check out Ma…Endpoints · 2mo ago↗ source
- STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbookTrump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own strategy.